Considering the metabolic differences between cell lines and stem cells, regarding their distinct dependency on specific amino acids, we tested whether the rLO cytotoxic effect observed in Jurkat cells could be translated to primary CD34 + hematopoietic stem-progenitor cells from leukemia patients and healthy bone marrow donors. Here, CD34 is linked to leukemia.